To date, only one study has examined MSL1’s role in colon cancer, demonstrating that MSL1 knockdown enhances cisplatin-induced DNA damage, promote apoptosis in HCT116 cells, and thereby facilitates tumor cell elimination [6]. Here, MSL1 is linked to malignant colon neoplasm.